Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Income from Discontinued Operations (2009 - 2026)

Revvity's (RVTY) quarterly Income from Discontinued Operations came in at -$1.7 million in Q3 2026, down 30.38% on a YoY basis from -$2.4 million in Q3 2025, and down 849.14% quarter-over-quarter from -$175000.0 in Q2 2026.

Analysis

Revvity (RVTY) Income from Discontinued Operations (2009 - 2026) Analysis & Trends

Revvity (RVTY) has reported Income from Discontinued Operations for 18 consecutive years, with -$1.7 million the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Income from Discontinued Operations fell 30.38% year-over-year to -$1.7 million; the trailing twelve-month figure through Jul 2026 stood at $188000.0 (down 97.12% YoY), and the FY2025 full-year result was $1.3 million, up 110.39% from the prior year.
  • Income from Discontinued Operations eased to -$1.7 million in Q3 2026 per RVTY's latest filing, from -$175000.0 in the prior quarter.
  • Across five years, Income from Discontinued Operations topped out at $544.6 million in Q2 2023 and bottomed at -$23.1 million in Q3 2023.
  • Historically, Income from Discontinued Operations has averaged $30.4 million across 5 years, with a median of $196500.0 in 2025.
  • The sharpest annual moves came in 2022 and 2023: Income from Discontinued Operations soared 8449.32% in 2022, then slumped 245.03% in 2023.
  • Over 5 years, Income from Discontinued Operations stood at $15.8 million in 2022, then plunged by 245.03% to -$23.0 million in 2023, then soared by 127.26% to $6.3 million in 2024, then sank by 58.59% to $2.6 million in 2025, then plunged by 164.06% to -$1.7 million in 2026.
  • According to Business Quant data, Income from Discontinued Operations over the past three periods registered -$1.7 million, -$175000.0, and $2.6 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -1.66 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 -1.66 Mn
Apr 5, 2026 -175,000.00
Dec 28, 2025 2.59 Mn
Sep 28, 2025 -569,000.00
Jun 29, 2025 -1.27 Mn
Mar 30, 2025 568,000.00
Dec 29, 2024 6.26 Mn
Sep 29, 2024 981,000.00
Jun 30, 2024 -17.25 Mn
Mar 31, 2024 -2.68 Mn
Oct 1, 2023 -22.97 Mn
Jul 2, 2023 -23.06 Mn
Apr 2, 2023 544.63 Mn
Jan 1, 2023 30.16 Mn
Oct 2, 2022 15.84 Mn
Jul 3, 2022 17.61 Mn
Apr 3, 2022 -7.11 Mn
Jan 2, 2022 6.10 Mn
Oct 3, 2021 20.11 Mn
Jul 4, 2021 18.07 Mn